Jieli (Shirley) Li, MD, PhD
Associate Professor-Clinical
Phone:
E-mail:
Mailing Address:
E314 Doan Hall
410 W 10th Ave.
Columbus, OH 43210
Biosketch
Jieli Shirley Li, MD, PhD, is an Associate Professor-Clinical at the Department of Pathology, and Co-Director at the Clinical Chemistry&Toxicology Laboratory. Dr. Li earned her MD and PhD from Shanghai Jiao-Tong University School of Medicine. Dr. Li completed her fellowship training in clinical chemistry at MD Anderson Cancer Center. Her clinical service and academic interests focus on implementing innovate laboratory tests for in vitro diagnosis, prognosis and treatment planning of cancer and endocrine diseases. Dr. Li has published more than 40 scientific articles and served as Ad Hoc reviewer for 10 journals. She also serves as board of director in national societies.
Academic and Medical Appointments
2024-Present Associate Professor-Clinical, Department of Pathology, The Ohio State University Wexner Medical Center
2019-2024 Assistant Professor-Clinical, Department of Pathology, The Ohio State University Wexner Medical Center
2019-Present Co-Director, Clinical Chemistry&Toxicology Laboratory, The Ohio State University Wexner Medical Center
2014-2016 Research Assistant Professor, Department of Physiology and Biophysics, University of Illinois at Chicago
2002-2004 Resident Physician, Department of Internal Medicine, Shanghai the 8th People's Hospital, China
Education and Training
2017-2019 Clinical Chemistry Fellow, Department of Pathology, University of Texas MD Anderson Cancer Center
2011-2014 Post-Doctoral Fellow, Department of Physiology and Biophysics, University of Illinois at Chicago
2009-2011 Post-Doctoral Fellow, Department of Medical Physiology, Texas A&M University Health Science Center
2004-2009 Ph.D. in Endocrinology, Shanghai Jiao-Tong University School of Medicine, China
1997-2002 M.D. in Clinical Medicine, Shanghai Jiao-Tong University School of Medicine, China
Selected Publications
- Li J*, Patton A, Lee JKY, Scheidegger M, Azaryan I, Sipos J, Nabhan F, Jones J, Algeciras-Schimnich A, Ringel MD*. Defining the Functional Sensitivity for The Siemens Atellica Calcitonin Assay: Insight from A Single-center Study. Endocr Pract. 2024 Aug 26:S1530-891X(24)00656-6. [PMID: 39197746] [*corresponding author]
- Li J*, Hatten-Beck M, Lee JKY, Hoofnagle AN*. Insights into insulin analog cross-reactivity: a comparative study of Siemens Atellica and LC-MS/MS. Endocrine. 2024 Jul 19. [PMID: 39030378] [*corresponding author]
- Alkhalaileh H, Wei R, Cordero Rivera A, Goksel M, Lee JKY, Mazzaferri Jr. E, Jones J, Li J. Evaluation of Age and Sex Differences on Contemporary Versus High-sensitivity Troponin I Measurement in Hospitalized Patients. J Clin Med. 2024 Apr 21;13(8):2428. [PMID: 38673701]
- Xu R, Zhang S, Li J*, Zhu J*. Plasma and serum metabolic analysis of healthy adults shows characteristic profiles by subjects' sex and age. Metabolomics 2024 Mar 16;20(2):43. [PMID: 38491253] [*corresponding author]
- Huang R, Shi J, Wei R, Li J. Challenges of insulin-like growth factor-1 testing. Crit Rev Clin Lab Sci. 2024 Aug;61(5):388-403. [PMID: 38323343]
- Alkhalaileh H, Wei R, Lee JKY, Jones J, Li J. Relationship between TSH and Free Thyroxine in Outpatient Cancer Patient Population. Endocrine. 2023 Nov;82(2):319-325. [PMID: 37286745]
- Franks CE, Li J, Martinez M, Farnsworth CW, Jones PM, Grenache DG, Meng QH, Gronowski AM. Utility of commercially available quantitative hCG immunoassays as tumor markers in trophoblastic and non-trophoblastic disease. Clin Chem. 2023 May 19:hvad045. [PMID: 37205831]
- Mahler K, Kerlin R, Jones J, Li J. Effects of Heparin on pH, Ionized calcium, Lactate and Potassium in Venous Whole Blood in Evacuated Tubes. Lab Med. 2023 Sep 5;54(5):e157-e160. [PMID: 37095624]
- Lee JKY, Cradic K, Singh RJ, Jones J, Li J. Discordance of insulin-like growth factor-1 results and interpretation on four different platforms. Clin Chim Acta. 2022 Dec 14;539:130-133. [PMID: 36528048]
- Zha L*, Li J*, Krishnan SM, Brennan MR, Zhang YV, Povse P, Kerlin R, Shively K, Oleksik F, Williams J, Sykes E, Sun Q. New Diagnostic Cutoffs for Adrenal Insufficiency after Cosyntropin Stimulation using Abbott Architect Cortisol Immunoassay. Endocr Pract. 2022 Jul;28(7):684-689. [PMID: 35487459] [*co-first author]
- Li J, Rietschlin J, Miller I, Weber C, Scheidegger M, Barringer S, Kerlin R, Williams J*. Evaluation of the Preanalytical Interference of Hemoglobin, Bilirubin or Lipids on Therapeutic Drug Monitoring Assays on Beckman Coulter AU Analyzers. Lab Med. 2022 Mar 7;53(2):172-176. [PMID: 34436600]
- Scarl RT, Balada-LIasat JM, Nowacki N, Solaro RJ, Williams J*, Li J*. Myocardial Injury, Inflammation and Prothrombotic Response Are Associated with Outcomes of COVID-19 Patients. Ann Cardiol Vasc Med. 2021: 4(1); 1041. [*corresponding author]
- Walker C, Shuster A, Weber C, Gebhardt K, Scheidegger M, Swartzwelder J, Williams J*, Li J*. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays. Ann Clin Lab Sci. 2021 Mar;51(2):241-244 [PMID: 33941564][*corresponding author]
- Yang HS*, Shemesh A*, Li J*, Xie T, Apple FS, Williams J, Zhao Z, Steel AD. No increase in the incidence of cardiac troponin I concentration above the 99th percentile by Siemens Centaur high-sensitivity compared to the contemporary assay. Clin Biochem. 2020 Dec 6:S0009-9120(20)30905-X. [PMID: 33296707][*co-first author]
- Li J, Chang HM, Banchs J, Araujo DM, Hassan SA, Wagar EA, Yeh ETH, Meng QH. Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin. Cardiooncology. 2020 Jan 2;6:1. [PMID: 32154027]
- Li J, Ma J, Wagar EA, Liang D, Meng QH. A rapid ultra-performance LC-MS/MS assay for determination of serum unbound fraction of voriconazole in cancer patients. Clin Chim Acta. 2018 Nov;486:36-41. [PMID: 30016626]
- Li J, Wagar EA, Meng QH. Comprehensive Assessment of Biotin Interference in Immunoassays. Clin Chim Acta. 2018 Oct 5;487:293-298 [PMID: 30296442]